After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Vanda Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Vanda Pharmaceuticals Inc is $276.19M. A total of 2.11 million shares were traded on the day, compared to an average of 2.30M shares.
In the most recent transaction, Polymeropoulos Mihael Hristos sold 24,288 shares of VNDA for 4.13 per share on Mar 05 ’24. After the transaction, the President and CEO now owns 1,871,730 company shares. In a previous transaction on Mar 05 ’24, Wijkstrom Joakim sold 9,229 shares at 4.21 per share. VNDA shares that SVP, Chief Marketing Officer owns now total 129,789.
Among the insiders who sold shares, Moran Kevin Patrick disposed of 8,902 shares on Mar 05 ’24 at a per-share price of $4.20. This resulted in the SVP, CFO & Treasurer holding 231,014 shares of VNDA after the transaction. In another insider transaction, Williams Timothy sold 8,941 shares at $4.18 per share on Mar 05 ’24. Company shares held by the SVP & General Counsel now total 196,825.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, VNDA has a high of $7.00 and a low of $3.30.
As of this writing, VNDA has an earnings estimate of $VND/AUD per share for the current quarter. EPS was calculated based on a consensus of NVIDIA Corporation estimates, with a high estimate of $Vanda Pharmaceuticals Inc. per share and a lower estimate of $VND/AED.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.47, while its Total Shareholder’s Equity was $504.93M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 3.00.
